• 1. State Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P. R. China;
  • 2. Department of Vascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650032, P. R. China;
  • 3. Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, P. R. China;
LUO Mingyao, Email: luomingyao@fuwai.com
Export PDF Favorites Scan Get Citation

In recent years, the diagnosis and management technology of type B aortic dissection (TBAD) has developed rapidly worldwide along with evidence-based medicine practice and clinical research data. But the standard clinical criteria are still limited. Based on this, the Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS) established an expert group dominated by aortic surgeons to collate and analyze the comprehensive literature data of acute and chronic, complicated and uncomplicated TBAD. And then, the group formulated and officially released the clinical practice guidelines for TBAD in 2022. In this paper, we interpreted and analyzed the main contents of the guideline in combination with domestic research, in order to provide reference and help for the clinical diagnosis and treatment of TBAD at the present stage in China.

Citation: HAN Hui, LUO Mingyao, SHU Chang. Interpretation of clinical practice guidelines for type B aortic dissection of the Society of Thoracic Surgeons and the American Association for Thoracic Surgery in 2022. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(7): 820-827. doi: 10.7507/1007-4848.202204039 Copy

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Interpretation of the assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A position paper from ESC/EHRA/AACA/APHRS
  • Next Article

    Interpretation of the methodological framework of clinical research on innovative medical devices